Kwong Lung Enterprise Statistics

Total Valuation

Kwong Lung Enterprise has a market cap or net worth of TWD 8.70 billion. The enterprise value is 10.18 billion.

Market Cap	8.70B
Enterprise Value	10.18B

Important Dates

The next estimated earnings date is Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	Jul 26, 2024

Share Statistics

Kwong Lung Enterprise has 151.08 million shares outstanding. The number of shares has increased by 0.17% in one year.

Current Share Class	n/a
Shares Outstanding	151.08M
Shares Change (YoY)	+0.17%
Shares Change (QoQ)	+1.40%
Owned by Insiders (%)	4.03%
Owned by Institutions (%)	4.19%
Float	88.21M

Valuation Ratios

The trailing PE ratio is 15.95 and the forward PE ratio is 10.85.

PE Ratio	15.95
Forward PE	10.85
PS Ratio	1.15
PB Ratio	1.52
P/TBV Ratio	1.53
P/FCF Ratio	19.95
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.31, with an EV/FCF ratio of 23.34.

EV / Earnings	18.58
EV / Sales	1.35
EV / EBITDA	14.31
EV / EBIT	18.36
EV / FCF	23.34

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.39.

Current Ratio	1.46
Quick Ratio	0.76
Debt / Equity	0.39
Debt / EBITDA	3.21
Debt / FCF	5.26
Interest Coverage	17.96

Financial Efficiency

Return on equity (ROE) is 9.45% and return on invested capital (ROIC) is 4.54%.

Return on Equity (ROE)	9.45%
Return on Assets (ROA)	3.89%
Return on Capital (ROIC)	4.54%
Revenue Per Employee	27.48M
Profits Per Employee	1.99M
Employee Count	275
Asset Turnover	0.84
Inventory Turnover	3.51

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.50% in the last 52 weeks. The beta is -0.01, so Kwong Lung Enterprise's price volatility has been lower than the market average.

Beta (5Y)	-0.01
52-Week Price Change	+5.50%
50-Day Moving Average	56.91
200-Day Moving Average	58.83
Relative Strength Index (RSI)	53.46
Average Volume (20 Days)	63,289

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kwong Lung Enterprise had revenue of TWD 7.56 billion and earned 547.94 million in profits. Earnings per share was 3.61.

Revenue	7.56B
Gross Profit	1.30B
Operating Income	557.94M
Pretax Income	681.05M
Net Income	547.94M
EBITDA	674.17M
EBIT	557.94M
Earnings Per Share (EPS)	3.61

Full Income Statement

Balance Sheet

The company has 963.19 million in cash and 2.30 billion in debt, giving a net cash position of -1.33 billion or -8.82 per share.

Cash & Cash Equivalents	963.19M
Total Debt	2.30B
Net Cash	-1.33B
Net Cash Per Share	-8.82
Equity (Book Value)	5.87B
Book Value Per Share	37.90
Working Capital	1.38B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 796.03 million and capital expenditures -359.84 million, giving a free cash flow of 436.18 million.

Operating Cash Flow	796.03M
Capital Expenditures	-359.84M
Free Cash Flow	436.18M
FCF Per Share	2.89

Full Cash Flow Statement

Margins

Gross margin is 17.23%, with operating and profit margins of 7.38% and 7.26%.

Gross Margin	17.23%
Operating Margin	7.38%
Pretax Margin	9.01%
Profit Margin	7.26%
EBITDA Margin	8.92%
EBIT Margin	7.38%
FCF Margin	5.77%

Dividends & Yields

This stock pays an annual dividend of 3.60, which amounts to a dividend yield of 6.25%.

Dividend Per Share	3.60
Dividend Yield	6.25%
Dividend Growth (YoY)	-5.35%
Years of Dividend Growth	1
Payout Ratio	98.68%
Buyback Yield	-0.17%
Shareholder Yield	6.08%
Earnings Yield	6.27%
FCF Yield	5.01%

Dividend Details

Stock Splits

The last stock split was on August 17, 2000. It was a forward split with a ratio of 1.05.

Last Split Date	Aug 17, 2000
Split Type	Forward
Split Ratio	1.05

Scores

Kwong Lung Enterprise has an Altman Z-Score of 2.81. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.81
Piotroski F-Score	n/a